We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
Within a little more than a decade, Ukraine has become a major global hub for clinical research patient recruitment. But today, the country is going through tremendously difficult times, meaning hundreds of clinical trials have been disrupted and patients are facing the potential loss of their treatment. In this episode of Industry Voice, we interview Yuriy Lebed, the CEO of Pharmaxi, a CRO based in Ukraine, which has been keeping clinical trials running and ensuring that patients keep receiving their treatment.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
